← Leaderboards
Farnoush Banaei-Kashani
University Of Colorado Denver
$1,646,406
Attributed
$4,915,259
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,915,259 · 3
By mechanism
R01$3,088,398 · 1
OT2$1,592,119 · 1
R21$234,742 · 1
Top collaborators
- Russell Paul Bowler7 shared
- Katherina Kechris-Mays6 shared
- Leslie A Lange4 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Ronald J Sokol$193,385,254
- Katherina Kechris-Mays$8,836,893
- Matthew R Taylor$5,502,265
- Rubin M Tuder$19,596,454
- Andrew P Feranchak$4,273,778
Others in their field
Other Emerging Leaders on “Research Personnel”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Joel A Lipkin · Four Points Technology, Llc$178,737,225
- Lynn Briscoe · Leidos Biomedical Research, Inc.$160,201,956
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$123,112,727
Research focus
Research PersonnelCohortMetabolomicsProteomicsGeneticDisease ProgressionMultiple OmicsNational Heart, Lung, And Blood InstitutePhenotypeNew Therapeutic TargetDistalBiologyMultidisciplinaryCause Of DeathMinorityNovel DiagnosticsInvestigationComplexCharacteristicsComputersClinical PhenotypeDisease PhenotypeData SetMolecular
Grant awards (7)
EMAI-COPD: An Ethical Multimodal AI Model for Preventive, Diagnostic, and Therapeutic Interventions in Chronic Obstructive Pulmonary Disease$1,592,119
OT2 · FY2025 · OD · contact PI
Multi-omic networks associated with COPD progression in TOPMed Cohorts$750,938
R01 · FY2023 · HL
Multi-omic networks associated with COPD progression in TOPMed Cohorts$753,955
R01 · FY2022 · HL
Multi-omic networks associated with COPD progression in TOPMed Cohorts$759,026
R01 · FY2021 · HL
Multi-omic networks associated with COPD progression in TOPMed Cohorts$824,479
R01 · FY2020 · HL
Omics Data Integration to Identify Disease Pathways in COPD$117,464
R21 · FY2018 · HL
Omics Data Integration to Identify Disease Pathways in COPD$117,278
R21 · FY2017 · HL